You have %itemCount% in your cart.Total being %total%
The price of this item will revert back to 300.00 AED at the end of this countdown.
Products will be delivered between 2 and 5.
Librela is a once-monthly injectable monoclonal antibody therapy designed to control pain associated with osteoarthritis (OA) in dogs.
Librela works by targeting nerve growth factor (NGF), a key contributor to osteoarthritis pain, helping improve comfort, mobility, and quality of life.
Key Benefits:
Provides long-lasting osteoarthritis pain control.
Administered once monthly by a veterinarian.
Targets NGF involved in pain signaling.
Helps improve mobility and daily comfort.
Indication: Control of pain associated with osteoarthritis in dogs.
Administration: Monthly injection under veterinary supervision.